541299 — Dr Lalchandani Labs Balance Sheet
0.000.00%
- IN₹60.37m
- IN₹39.60m
- IN₹41.86m
Annual balance sheet for Dr Lalchandani Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Preliminary |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 31 | 22.9 | 33 | 41.4 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 58 | 53.1 | 58.8 | 67.6 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 110 | 94.8 | 109 | 128 |
| Net Property, Plant And Equipment | 50.3 | 37 | 32.6 | 30.7 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 177 | 150 | 157 | 176 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 53.2 | 50.3 | 56.6 | 33.8 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 88 | 54.5 | 57.9 | 34.7 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 89.2 | 95.4 | 99.6 | 141 |
| Total Liabilities & Shareholders' Equity | 177 | 150 | 157 | 176 |
| Total Common Shares Outstanding |